Cover
Vol. 4 No. 1 (2026)

Published: June 1, 2026

Pages: 149-157

Research Article

Antibacterial Evaluation of Volkameria inermis Leaves Cultivated in Iraq

Abstract

Background: Volkameria inermis is a medicinal plant traditionally used for its antimicrobial, anti-inflammatory, and antioxidant properties. Owing to the increasing resistance of pathogenic bacteria to conventional antibiotics, there is a growing interest in exploring plant-derived compounds as alternative therapeutic agents.  Objectives: The objective of this study was to assess the effectiveness of an ethanolic extract of Volkameria inermis leaves by using an ethanolic solvent that was eighty percent strength. Methods: Samples of leaves were gathered from the center area of Iraq (Al-Musayab), and washed, sorted, and dried in a shaded environment. Through the use of 800 milliliters of 80% ethanol, an extract of Volkameria inermis leaves was created and dried using a rotary evaporator, it was stored in petri dishes that had been sterilized, and one milligram of the extract was dissolved in one milliliter of dimethyl sulfoxide (DMSO). To conduct the antibacterial test using the agar well diffusion technique, the solution was serially diluted to a concentration of 1 mg/ml. The efficacy of an ethanol extract against bacteria as assessed by well diffusion method. Results: When tested against both (Staphylococcus aureus) and (Salmonella typhi) bacteria, the ethanolic extract of Volkameria inermis demonstrated a notable antibacterial effect at a concentration of 500 μg/ml, which resulted in more inhibition zones than the antibiotic ciprofloxacin.  Conclusion: The outcomes of this study demonstrated that the Volkameria inermis plant outperformed the drug ciprofloxacin in its antibacterial activity against Staphylococcus aureus and Salmonella typhi.

References

  1. Tawfeeq TA, Jasim GA, Nasser AA, Al-Sudani BT. Isolation of lupeol and gallic acid with cytotoxic activity of two different extracts from the leaves of iraqi conocarpus erectus L. Res J Pharm Technol. 2021;14(7):3495–503.
  2. Kumar R, Kumar B, Kumar A, Kumar A, Singh M. GC-MS analysis of Phytocomponents in the Methanol Extract of Premna latifolia Roxb. Pharmacognosy Research. 2022;14(1):19-23
  3. Uritu CM, Mihai CT, Stanciu GD, Dodi G, Alexa-Stratulat T, Luca A, Leon-Constantin MM, Stefanescu R, Bild V, Melnic S, Tamba BI. Medicinal plants of the family Lamiaceae in pain therapy: A review. Pain Res Manag. 2018; 2018:7801543.
  4. Starr F, Starr K, Loope L. Clerodendrum inerme (Seaside clerodendrum, Verbenaceae). US Geol Surv Biol Resour Div, Haleakala Field Station, Maui, Hawaii. 2003;1-9.
  5. Harshitha K, Nishteswar K, Harisha CR. Pharmacognostical and preliminary phytochemical investigations on different parts of Bulbophyllum neilgherrense Wight. J Ayurveda Integr Med. 2013;2(4):259-69.
  6. Ibrahim SRM, Alshali KZ, Fouad MA, Elkhayat ES, Al Haidari RA, Mohamed GA. Chemical constituents and biological investigations of the aerial parts of Egyptian Clerodendrum inerme. Bull Fac Pharm Cairo Univ. 2014;52(2):165-70.
  7. Hurakadli SB, Chaithra SH, Ravikrishna S. A review on Clerodendrum inerme (L) Gaertn: The biological source of Agnimantha. Aayushi Int Interdiscip Res J. 2018;5(1):129-32.
  8. Wisessombat S, Tayeh M. In vitro wound healing potential and antimicrobial activity of Clerodendrum inerme leave extracts. Pharmacogn J. 2021;13(6):1542-8.
  9. Çaliş I, Hosny M, Yürüker A, Wright AD, Sticher O. Inerminosides A and B, two novels complex iridoid glycosides from Clerodendrum inerme. J Nat Prod. 1994;57(4):494-500.
  10. Al-Snafi AE. Chemical constituents and pharmacological effects of Dalbergia sissoo: A review. IOSR J Pharm. 2017;7(2):59-71.
  11. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 2016;6(2):71-79.
  12. Reller LB, Weinstein M, Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clinical infectious diseases. 2009 Dec 1;49(11):1749-55.
  13. AlAhadeb JI. New combination of drugs to combat Escherichia coli DSM1103 QCDSM by reducing antibiotic ciprofloxacin standard dose using response surface methodology. J Infect Public Health. 2021;14(12):1815-21.
  14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2024.
  15. Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull. 2002;25(12):1600-3
  16. Thai T, Draughn GL, Ganti L. Ciprofloxacin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
  17. Li S, Wang Y, Zhao C, Li X, Li Y, Chen Y. The combination of allicin with domiphen is effective against microbial biofilm formation. Front Microbiol. 2024; 15:1341316.
  18. Wisessombat S, Tayeh M. In vitro wound healing potential and antimicrobial activity of Clerodendrum inerme leaf extracts. Pharmacogn J. 2021;13(6):1542-8.
  19. Khan AV, Khan AA. Antibacterial potential of Clerodendrum inerme crude extracts against some human pathogenic bacteria. Orient Pharm Exp Med. 2006;6(4):306-11.
  20. Barman M, Barman A, Ray S. Clerodendrum inerme (L.) Gaertn.: a critical review on current progress in traditional uses, phytochemistry, pharmacological aspects and toxicity. Phytochem Rev. 2024;23(6):1675-1736.